Meet the 2025 New England finalists

Errik is the CEO of Alloy Therapeutics.

Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners spanning academia, biotech, and the largest biopharma companies, Alloy democratizes access to pre-competitive tools, technologies, services, and company creation capabilities foundational for discovering and developing therapeutic biologics across six modalities: antibodies, TCRs, RNA medicines, peptides, cell therapies, and drug delivery. Partners may access all current and future technologies either through a discovery service relationship or for a flat annual fee via Alloy’s Innovation Subscriptions offering. As a reflection of Alloy’s relentless commitment to the scientific community, it reinvests 100% of its revenue in innovation and in facilitating access to innovation.

Elisabet is the CEO of Aura Biosciences, Inc.

Aura Biosciences is a clinical-stage biotechnology company focused on developing precision therapies for solid tumors that aim to preserve organ function. Our lead candidate, bel-sar (AU-011), is currently in late-stage development for primary choroidal melanoma and in early-stage development in other ocular oncology indications and bladder cancer. Aura Biosciences is headquartered in Boston, MA. Our mission is to grow as an innovative global oncology company that positively transforms the lives of patients. For more information, visit aurabiosciences.com. Follow us on X (formerly Twitter) @AuraBiosciences and visit us on LinkedIn.

John is the Co-Founder, Chairman and CEO of BeiGene.

BeiGene, which plans to change its name to BeOne Medicines Ltd., is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 11,000 colleagues spans six continents.

Claire is the CEO of Bicara Therapeutics, Inc.

Bicara Therapeutics is a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Our lead program, ficerafusp alfa, is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-β). Through this dual-targeting mechanism, ficerafusp alfa has the potential to exert potent anti-tumor activity by simultaneously blocking both cancer cell-intrinsic EGFR survival and proliferation, as well as the immunosuppressive TGF-β signaling within the tumor microenvironment. Ficerafusp alfa is initially being developed in head and neck squamous cell carcinoma, where there remains a significant unmet need.

Paul is the CEO of Black Kite.

Black Kite provides companies with a comprehensive, real-time perspective on third-party cyber risks. It empowers them to make informed, proactive decisions that prevent business disruptions and enhance supply chain resilience. Featuring unique collaboration tools, Black Kite enables businesses to engage directly with vendors to report, mitigate, and reduce risks, strengthening their own resilience while simultaneously bolstering the security of their vendors’ organizations. Recognized as a Strong Performer in the Gartner® Peer Insights™ 2023 ‘Voice of the Customer’: IT Vendor Risk Management Tools, Black Kite has earned praise from customers, with one noting, “I've worked with other tools and Black Kite by far has the best data in the space.”

Kate is the CEO of Blueprint Medicines.

Blueprint Medicines is a global biopharmaceutical company that invents life-changing medicines. We seek to improve and extend patients' lives by solving important medical problems, with a focus on allergy/inflammation and oncology/hematology. Our approach combines deep scientific expertise, modality-agnostic drug discovery capabilities, and a proven track record of R&D success. Currently, we are commercializing our approved medicine AYVAKIT/AYVAKYT® (avapritinib) in the U.S. and Europe, as well as in other regions of the world through partnerships.

Nabiha is the CEO and Co-Founder of Cellino Biotech, Inc.

Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacements for patients. Cellino’s technology leverages AI co-pilots and a laser-based cell management process to automate the artisanal manufacturing of induced pluripotent stem cells (iPSCs), which can be differentiated into any cell type in the body. This enables the development of disease-reversing and potentially curative therapies for a range of chronic degenerative conditions, including diabetes, heart disease, obesity, and Parkinson’s. The company’s vision is to transform medicine to enhance healthy lifespan for billions of people across generations.

Siva is the CEO and Co-Founder of Cohere Health.

Prior authorization (PA) is a complex, often manual process to show that care is medically appropriate and to ultimately improve patient outcomes. Frustrations often arise around PA-associated care delays and admin burden; in an annual AMA PA survey, 93% of physicians reported care delays associated with PA. For innovative health plans seeking to improve PA, intelligent prior authorization solutions can help. By automating and simplifying outdated processes, these solutions can support health plans’ efforts to improve care quality and costs. Cohere’s platform goes beyond approving or denying authorization requests. Using AI/ML, predictive analytics, and robust clinical expertise, we help providers deliver more personalized, efficient care. Intelligent prior authorizations enable health plans to move away from transactional processes and toward a more comprehensive, valuable approach that improves care and outcomes and creates a better PA process. Cohere is unique in offering both a licensed platform-as-a-service (PaaS) intelligent PA solution and a fully delegated utilization management (UM) solution, which offer health plans the flexibility to support in-house processes and/or outsource UM operations for specific specialties.

Jeff is the CEO of ConcertAI.

ConcertAI is the leader in predictive and generative AI SaaS and real-world data solutions, transforming healthcare and life sciences. Focused on optimizing oncology care through data-driven insights, ConcertAI provides advanced solutions that power clinical decision-making, accelerate research, and improve cancer patient outcomes. Its offerings include CARAai™, a multi-modal data management, predictive and generative AI platform that accelerates research and enables AI-driven workflows; TeraRecon Oncology Suite, an AI-diagnostic toolset enhancing early cancer detection and accurate diagnosis; CancerLinq, a network of leading cancer centers dedicated to quality and research, providing real-world oncology insights; and its Digital Trial Solution, an AI platform improving clinical trial screening and patient matching, increasing trial accessibility and effectiveness. Serving oncology, hematology, biotech, AI, and medical imaging markets, ConcertAI delivers AI-powered and real-world data services and solutions, driving innovation in AI and healthcare. Its commitment to technological and medical excellence has led to partnerships with NVIDIA, NeoGenomics, and DeepHealth, uniting AI and healthcare leaders to build next-gen solutions.

Dan is the CEO of Context Labs.

Context Labs is an enterprise technology company, founded from Dan’s research at MIT. It is dedicated to sourcing, organizing, contextualizing, and securing the world’s climate information. The company synthesizes disparate information from all available data sources to establish a more comprehensive and contextual understanding of the ‘Ground Truth’ carbon intensity profile of energy operations. Context Labs technology instantiates a digital twin of a customer’s facilities, enabling real time tracking and tracing of all data flows.  It is AI-enabled and builds an interconnected network graph of the customer's operations.  This provides the foundation for Computational AI, allowing deeper integration into Generative AI, enabling language-based queries on emissions, standards, methods, and operations. An inventor, technology entrepreneur and CEO for more than 30 years, Dan has founded six companies and built technologies, and products that have been used by billions of Internet users. Context Labs has offices in Amsterdam, Cambridge, and Houston.

Michael is the CEO of eGenesis, Inc.

eGenesis is pioneering a genome engineering-based approach to develop safe, effective transplantable organs to end the global organ shortage. Its platform uniquely addresses cross-species molecular incompatibilities and viral risk via its proprietary genetic engineering platform to improve outcomes for patients in need of a transplant. With demonstrated preclinical success, eGenesis is advancing programs in kidney transplantation, acute liver failure, and heart transplantation.

Dipal is the CEO of Entrada Therapeutics.

Headquartered in Boston’s Seaport community, Entrada Therapeutics is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company’s Endosomal Escape Vehicle (EEV™)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA-, antibody- and enzyme-based programs for the potential treatment of neuromuscular, ocular, metabolic and immunological diseases, among others. The Company’s lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

Carlos is the CEO of Feast and Fettle.

At Feast & Fettle, we are on a mission to bring joy and connection back to the table. We understand the choice you face when it comes to mealtime: spend hours planning and cooking to feed your family well or settle for takeout or something overly processed to save precious time. So, we started Feast & Fettle to make it easier for families to enjoy quality meals together. Our chefs create wholesome, homemade meals using fresh produce, recognizable ingredients, and the same care as you would in your own kitchen. From there, each meal is sustainably packaged and delivered to your doorstep by our team. Our promise is simple: a full-service hospitality experience that supports you, so you can spend time doing the things you love with the ones you love most. This promise is in everything we do, from supporting our team members in and beyond the workplace, to giving back to the communities we serve. Because food is so much more than calories, it’s nourishment. It brings warmth, comfort, and connection. And nothing is more powerful than a shared meal.

Norma is the CEO of Gordon Brothers.

Gordon Brothers, the leading global asset experts, is a 122-year-old company with more than 30 offices across the globe (North America, EMEA, APAC) specializing in providing liquidity solutions for clients based on the value of their hard assets. The firm’s offerings can be categorized under three pillars: 1) Asset Services, in which its provides businesses an understanding of the true value of their assets. Offerings in this category include valuations and field exams, equipment management, lease restructuring and termination, and advisory services.; 2) Asset Lending & Financing, in which it provides capital. Offerings include Asset-based lending and equipment finance; 3) Asset Trading, in which the firm monetized assets for companies while protecting their brand. Offerings include purchase and sale, inventory programs, store and website closures, and consumer retention programs. These offerings allow Gordon Brothers to provide custom solutions across the asset lifecycle – all under one platform.

Brooke is the CEO and Co-Founder of knownwell.

knownwell is a primary care company specializing in weight management, built for the millions of Americans who have been told their weight is the problem, regardless of their unique health concerns. More than 110 million Americans have obesity, yet, most don’t have access to comprehensive care. knownwell practices evidence-based medicine that supports a patient’s unique goals. Stigmatizing patients does not promote wellness and leads to worse health outcomes. knownwell prides itself on making weight-inclusive healthcare more accessible, offering full-coverage care online or in-person through patient insurance without sign-up or membership fees.

Kevin is the CEO and Founder of Lydonia.

Lydonia provides AI solutions and advisory services that help businesses streamline operations, strengthen security, and unlock the true value of their data. Our expertise in AI, automation, data, and security enable organizations to eliminate inefficiencies, reduce risk, and drive measurable business impact. We make AI tangible and practical, equipping businesses with solutions that enhance decision-making, improve data accuracy, and automate complex processes. By integrating AI-driven automation, data transformation, and Zero Trust security, we help clients increase efficiency, protect critical assets, and maximize their technology investments. At Lydonia, we don’t just implement technology—we turn AI into a real, accessible tool that delivers immediate value. Our team partners closely with clients to design and deploy AI-powered strategies that create meaningful, lasting impact.

Joanne is the Co-owner of Flour Bakery/Myers+Chang, LLC.

Flour is a bakery and cafe with 9 (soon 10) locations in the Boston area. We offer amazing food, warm welcoming service, and a commitment to making everyone who comes into Flour leave happier than when they walked in. We offer breakfast pastries, cookies, cakes, pies, breads, pizzas, sandwiches, salads, soups, and homemade seltzers. We pride ourselves on making everything in house. Myers+Chang is a fun and funky Asian restaurant in the South End in Boston that routinely wins Best of Boston awards and is beloved in the community.

Maya is the Founder and CEO of Outcomes4Me, Inc.

Outcomes4Me uses AI and machine learning to help cancer patients navigate their care and access evidence-based, personalized treatment information. When patients provide their health information, our free platform offers both doctor-approved and FDA-approved guidance based on their diagnosis, as well as relevant clinical trials and genetic and genomic testing the patient should consider. We support over 250,000 patients with cancer.

Yogesh is the CEO of Progress Software Corporation.

Progress (Nasdaq: PRGS) empowers organizations to achieve transformational success in the face of disruptive change. Our software enables our customers to develop, deploy and manage responsible, AI-powered applications and experiences with agility and ease. Customers get a trusted provider in Progress, with the products, expertise and vision they need to succeed. Over 4 million developers and technologists at hundreds of thousands of enterprises depend on Progress.

Sarah is the Co-Founder and President of radius financial group.

Founded in 1999, radius financial group has redefined the mortgage industry by combining best-in-class technology with a deeply personal approach to lending. As an independent mortgage bank, radius offers a diverse suite of over 100 loan products, empowering borrowers with tailored solutions that fit their financial goals. With a mission of "Making Mortgages Better", the company prioritizes efficiency, transparency, and a seamless customer experience, ensuring homeownership remains accessible and rewarding. Under the visionary leadership of Co-Founder Sarah Valentini, radius has earned recognition as one of the nation’s top mortgage lenders, consistently ranking as Top Places to Work and the Boston Globe’s Top 100 Women-Led Businesses. Beyond financial success, radius is deeply committed to community engagement, diversity, and innovation, investing in initiatives that drive positive change. Today, radius stands at the forefront of mortgage lending, continuously evolving to meet the demands of the modern housing market.

Tameem is the Founder of RapDev.

RapDev is a Boston-based engineering consulting firm specializing in cloud-native best practices. Our U.S.-based team of Site Reliability Engineering (SRE) and DevSecOps professionals have hundreds of platform implementations for Fortune 500 companies under their belt. As a Premier Datadog Partner and ServiceNow Elite Partner, RapDev focuses on implementing and integrating these platforms to enhance observability, optimize digital workflows, and improve both end-user and developer experiences. The company’s tailored solutions cater to the unique needs of each client, ranging from small and medium-sized businesses to Fortune 100 companies. RapDev is committed to contributing to the open-source community and regularly shares their expertise to drive innovation. The company’s services include agile software development, CI/CD pipeline development, and comprehensive DevSecOps transformations that help organizations accelerate their code deployment processes. Recognized for its rapid growth, RapDev has been featured several times on the Deloitte Technology Fast 500, Inc. 5000, and Forbes Best Startup Employers lists, underscoring its commitment to excellence and customer success.

JR is the Founder and CEO of Shift Group Holdings, Inc.

Shift Group bridges the gap between military veterans, former athletes, and the business world through coaching and career upskilling. Our mission is to help these individuals unlock their unique skills and experiences and match them with top-tier companies in need of resilient, coachable, and team-oriented professionals. The Shift Connect platform accelerates learning and streamlines the hiring process by connecting employers with pre-vetted candidates who are ready to excel. Customers reduce hiring time, lower costs, increase growth rates, and improve retention. Shift Group is committed to helping businesses build high-performing teams and supporting veterans and athletes in their career development.

Tom Kostopoulos is the CEO of StemWave.

Since our first product launch in 2022, StemWave has quickly become one of the leading non-invasive regenerative technologies available in the U.S. available at over 500 offices in 48 states. StemWave's first product, Modus - is a non-invasive shockwave technology for orthopedic indications. Within 18 months of product launch StemWave has quickly become the category leader in orthopedic shockwave achieving mass distribution with a 97% success rate with private practice integrations. Over the coming years StemWave will continue to make advanced non-invasive technology available to those who need it most and remain committed to improving the quality of living around the world through innovation and distribtion.

Stephen is the Founder and CEO of The AGL Group.

The AGL Group is a family-owned Domestic and International Third-Party Logistics (3PL) firm, co-founded in 2013 by Stephen Zambo. Headquartered in Weymouth, MA, with offices in Jacksonville, FL, and Barranquilla, Colombia, we specialize in the import and export of Air, Ocean, and Trucking freight. Our expertise lies in handling heavy and overweight commodities, including Lumber, Logs, Pallets, Recycling Materials, Metals, and products in the Food and Beverage sector. We provide end-to-end logistics solutions, offering: International Freight Forwarding – Domestic and international transportation via Air, Ocean, and Trucking.; Domestic Trucking – Nationwide coverage for full truckload (FTL), less-than-truckload (LTL), and spec; Compliance & Documentation – Managing customs, regulatory requirements, and international trade documentation.; Banking & Financial Coordination – Supporting transactions and letters of credit for seamless global trade.; Managed Services – Tailored logistics programs and operational support to meet unique client needs. As a true full-service logistics provider, The AGL Group combines industry expertise with personalized service to deliver efficient, reliable, and cost-effective supply chain solutions worldwide.

Krenar is the Founder and CEO of Tive, Inc.

Tive is the global leader in supply chain and logistics visibility technology. More than 950 global shippers, logistics service providers, and retailers use Tive to monitor shipment location and condition in real time, gain actionable insights, and ensure end-customer satisfaction. Tive's cloud platform, patented sensor technology, and 24/7 Live Monitoring services reduce excursions and delays, minimize rejected loads, and decrease theft, damage, and spoilage. Tive's Green Program reduces electronic waste by renewing and recirculating trackers and extending their life. Customers count on Tive to ensure that shipments are delivered on time and in full—because every shipment matters.

Itai is the Co-Founder and CCO of Tomorrow.io.

Selected by TIME Magazine as one of the TOP 100 Most Influential Companies in the world, Tomorrow.io is the world’s leading Resilience Platform™. Supercharged by next-generation space technology, cutting-edge generative AI, and proprietary modeling capabilities, global leaders, including JetBlue, The United States Air Force, and Uber, rely on Tomorrow.io to predict, improve decision-making, and solve for any weather or climate-related challenge. From innovative weather intelligence and actionable insights to early warning systems and climate adaptation, organizations can predict impact, mitigate risk, and ensure operational resilience with Tomorrow.io.

Matt is the Co-Founder and CEO of Tracksmith.

Founded in Boston in 2014, Tracksmith is an independent running brand built on a deep love for the sport. We craft products, tell stories and create experiences that enrich the running lifestyle. We celebrate the amateur spirit and seek to inspire the personal pursuit of excellence. As a New England based brand, we live here, we work here, and we race here. We relish everything New England means to running and to us. This place, and its historical significance to our sport, are at the core of our identity. When we launched in 2014, we set up shop in Wellesley, MA at the halfway point of the Boston Marathon. In 2017, we moved 13.1 miles down the course to 285 Newbury Street. Our first permanent retail store, the Trackhouse is a community hub for runners. In 2023, we expanded that experience opening two other retail flagship Trackhouses: one in London, UK and the other in Brooklyn, NYC.

Mickey is the CEO and Co-Founder of Transmit Security.

Transmit Security is the leader in customer identity and access management (CIAM), empowering enterprises to secure digital identities without compromising user experience. Transmit Security’s Mosaic unifies customer identity and anti-fraud into one platform – delivering seamless, orchestrated user experiences with built-in fraud prevention, so enterprises can modernize CIAM or complement existing CIAM infrastructure, without compromise and at business speed. Designed for flexibility, Mosaic enables businesses to adopt passwordless authentication, risk-based access controls, identity verification, and advanced fraud detection in a single, cloud-native solution. By reducing reliance on outdated identity technologies and fragmented fraud solutions, Transmit Security helps organizations eliminate friction, lower fraud losses, and accelerate business growth. Global enterprises trust Transmit Security to deliver secure, seamless authentication and fraud prevention at scale—protecting trillions of customer interactions worldwide.

Rakesh is the President and Co-Founder of Transmit Security.

Transmit Security is the leader in customer identity and access management (CIAM), empowering enterprises to secure digital identities without compromising user experience. Transmit Security’s Mosaic unifies customer identity and anti-fraud into one platform – delivering seamless, orchestrated user experiences with built-in fraud prevention, so enterprises can modernize CIAM or complement existing CIAM infrastructure, without compromise and at business speed. Designed for flexibility, Mosaic enables businesses to adopt passwordless authentication, risk-based access controls, identity verification, and advanced fraud detection in a single, cloud-native solution. By reducing reliance on outdated identity technologies and fragmented fraud solutions, Transmit Security helps organizations eliminate friction, lower fraud losses, and accelerate business growth. Global enterprises trust Transmit Security to deliver secure, seamless authentication and fraud prevention at scale—protecting trillions of customer interactions worldwide.

Kevin is the CEO of Unreal Brands.

UNREAL is a mission-based brand that is creating the new reality of what candy can be. UNREAL is reinventing iconic candy products - such as Peanut Butter Cups, Coconut Bars, Candy Coated Chocolate Gems and Caramel Peanut Nougat Bars - with simple, real ingredients, way less sugar and, importantly, truly incredible taste, unlocking the joy, fun and shareability in this impactful and meaningful category. UNREAL is leading the charge to bring energy and growth to this aisle in the grocery store - offering consumers a better choice that is not burdened by harmful dyes, excess sugar and artificial ingredients. UNREAL is a leading brand in the better-for-you confection category, growing rapidly over the past several years in a purposeful and sustainable way. UNREAL is inviting consumers back to the candy aisle, growing the size of the total category and setting it up for long term success and growth. The brand continues to accelerate its growth through exciting new product launches, new distribution gains to serve more consumers and by continuing to meet the needs of its core consumers today. UNREAL products can be found nationwide in all major retailers including Target, Walmart, Costco, Whole Foods Market, Kroger and Publix.